Ginkgo Bioworks  Inc. logo

Ginkgo Bioworks Inc.

DNA | NYSE
Chart Builder DCF Calculator
$7.98
+$0.10 (+1.27%)
At close: Sep 21, 2026, 4:00 PM ET
$7.90
-$0.08 (-1.00%)
Pre-market: Sep 22, 2026, 5:48 AM ET

Market Data

Market Cap
$514.76M
Enterprise Value
$623.24M
Beta
1.77
Average Volume
1.22M
Shares Outstanding (Diluted)
62.09M
Shares Change YoY
13.19%
Institutional Ownership
54.29%
Exchange
NYSE
ISIN
US37611X2099

Price Performance

Price Change 1M
9.6%
Price Change 3M
-9.9%
Price Change 6M
8.4%
Price Change YTD
-8.3%
Price Change 1Y
-33.7%
Price Change 3Y
-88.7%
Price Change 5Y
-98.4%
1M CAGR (ann.)
-7.3%
1Y CAGR (ann.)
-28.8%
5Y CAGR (ann.)
-54.2%
All-Time CAGR
-51.7%

Valuation

PE Ratio
-1.59
Forward PE
N/A
PEG Ratio
-0.10
Forward PEG
0.08
PS Ratio
4.66
Forward PS
5.40
PB Ratio
1.24
P/FCF Ratio
-2.72
P/Adj. FCF Ratio
-2.05
P/OCF Ratio
-2.91
EV/Sales
5.57
EV/EBIT
-2.11
EV/EBITDA
-2.98
EV/FCF
-3.25
Earnings Yield
-62.9%
FCF Yield
-36.8%
Adj. FCF Yield
-48.8%

Financial Health

Net Cash
$302.16M
Total Debt
$404.11M
Cash & Short-Term Investments
$302.16M
Total Assets
$990.05M
Current Ratio
4.57
Quick Ratio
4.57
Debt / Equity Ratio
0.96
Debt / EBITDA
-1.93
Debt / FCF
-2.11
OCF / Debt
-0.43
Interest Coverage
0.00
Altman Z-Score
-8.89
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
80.1%
Operating Profit Margin
-259.9%
EBITDA Margin
-187.0%
Net Profit Margin
-260.0%
FCF Margin
-171.6%
Adj. FCF Margin
-227.3%
SBC / Revenue
55.7%
SBC Impact (per share)
-32.5%

Returns

Return on Assets
-29.4%
Return on Equity
-60.2%
Return on Invested Capital
-31.6%
Return on Capital Employed
-31.7%
Return on Tangible Assets
-30.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
-30.0%
Revenue CAGR 5Y
-3.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
67.5%
EPS CAGR 5Y
62.1%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
28.5%
FCF CAGR 5Y
11.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
11
EPS Growth Next 3Y
18.5%
Revenue Growth Next 3Y
48.9%
Earnings Date
Nov 4, 2026
EPS Estimate (next Q)
-$0.58
EPS Growth Est (next Q)
-60.0%
Revenue Est (next Q)
$21.57M
Revenue Growth Est (next Q)
-44.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
-37.3%

Cash Flow

Operating Cash Flow
$-172.08M
Free Cash Flow
$-191.95M
Adj. Free Cash Flow
$-254.27M
FCF Per Share
-$3.06
OCF Per Share
-$2.74
OCF/S Ratio
-152.2%

Income Statement

Revenue
$111.86M
Gross Profit
$89.6M
Operating Income
$-290.69M
EBITDA
$-209.15M
Net Income
$-290.8M
EPS (Diluted)
-$5.02
Revenue / Employee
$230.65K
Profit / Employee
$-599.59K
Employees
485

© 2026 bestshares.com. All rights reserved.